Health

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

DailyTrendDailyTrend
Oct 1, 2026 - 05:00
 0  0
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

U.S. Rejects U.N. Declaration on Preparing for Future Pandemics

U.S. Rejects U.N. Declaration on Preparing for Future P...

DailyTrend Sep 26, 2026  0  1

FDA Approves Juvmo (tavapadon) for the Treatment of Par...

DailyTrend Sep 29, 2026  0  1

Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters

Angiographic Catheter Recall: Boston Scientific Removes...

DailyTrend Sep 26, 2026  0  1

U.S. Food and Drug Administration Approves Expanded Ind...

DailyTrend Oct 1, 2026  0  0

FDA Approves Degevma (denosumab-adet), a Biosimilar to ...

DailyTrend Sep 30, 2026  0  0

The Most Disturbing 2000s Reality Show Doesn’t Seem So Crazy Anymore

The Most Disturbing 2000s Reality Show Doesn’t Seem So ...

DailyTrend Oct 1, 2026  0  0